Stay updated on Daratumumab in Untreated Myeloma: Transplant Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in Untreated Myeloma: Transplant Clinical Trial page.

Latest updates to the Daratumumab in Untreated Myeloma: Transplant Clinical Trial page
- Check6 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label was updated from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check13 days agoChange DetectedA banner announces that NIH is transitioning to use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with links to updates and FAQs.SummaryDifference0.8%

- Check20 days agoChange DetectedThe footer site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check27 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry (v3.7.0) was added to the study record history. This indicates an updated version of the page.SummaryDifference0.1%

- Check69 days agoChange DetectedThe study record history adds a new revision entry (v3.6.6) and removes the previous revision (v3.6.5), updating the list of versions shown for this record. This represents an update to the study's history documentation.SummaryDifference0.1%

Stay in the know with updates to Daratumumab in Untreated Myeloma: Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in Untreated Myeloma: Transplant Clinical Trial page.